Case Report: Advanced IgA nephropathy with psoriasis and a complex clinicopathologic course. (PubMed, Front Nephrol) - Sep 24, 2026 - "Targeted-release budesonide and deucravacitinib were started together. This case is best interpreted as a clinicopathologic observation rather than proof of drug efficacy. Biopsy-defined activity and chronicity helped explain the discordant changes in proteinuria and kidney function, while the longitudinal course generated a testable but unproven hypothesis of a possible inflammatory connection between psoriasis and IgA nephropathy."
Journal • Dermatology • Fibrosis • Glomerulonephritis • IgA Nephropathy • Immunology • Nephrology • Psoriasis • Renal Disease
|
|
Boyang Xu; Dan Shu; Lerui Wang; MinXia Li
|